Viral mimic systems and other tech platforms could enable local testing of vaccine candidates and antiviral therapies. This is important in the context of low-resourced health settings, Africa’s focus on increasing its vaccine manufacturing, and…
Continue Reading
News Source: medicalxpress.com
Leave a Reply